Biggest News Aggregation in the World
📰 Confirmatory Phase News

Confirmatory Phase News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Confirmatory Phase. Real-time updates on events, politics, business and more.

© 2023 Tonix Pharmaceuticals Holding Corp. INVESTOR PRESENTATION NASDAQ: TNXP Version P04 88 September 25 , 2023 (Doc 1321 ) - Form 8-K -September 25, 2023 at 04:40 pm EDT

T ianeptine - tianeptine 1 Stablon. Summary of product characteristics. Les Laboratoires Servier Industrie ; 2014. 2 PubChem. Accessed November 10, 2022....
United States Dapirolizumab Letolizumab Aglycosyl Ruplizumab Cyclobenzaprine Protectic Clin Rheumatol Zembrace Symtouch Edward Jenner

Biogen Inc.: FDA Accepts Eisai's Filing of a Supplemental Biologics License Application and Grants Priority Review for Traditional Approval of LEQEMBI (lecanemab-irmb) for the Treatment of Alzheimer's Disease

Confirmatory Phase 3 Clarity AD data to be evaluated by FDA in determining whether to convert accelerated approval of LEQEMBI to a traditional approval Priority Review accelerates FDA review time with
New Zealand United Kingdom United States Dennis Riedl Haruo Naito Christophera Viehbacher

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

FDA Accepts Eisai's Filing of a Supplemental Biologics License Application and Grants Priority Review for Traditional Approval of LEQEMBI™ (lecanemab-irmb) for the Treatment of Alzheimer's Disease

/PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge,...
New Zealand United Kingdom United States Haruo Naito Christophera Viehbacher Mike Hencke

Prothena Corporation plc: Prothena to Present Data on Survival Benefit Observed in Completed Phase 3 Study of Drug Candidate Birtamimab in Patients with Mayo Stage IV AL Amyloidosis at the ASH 2022 Meeting

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that
United States Jennifer Zibuda Michael Bachner Morie Gertz American Society Of Hematology Conference Investor Relations Communications

Prothena : Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Financial Guidance and Business Highlights - Form 8-K

Prothena Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Financial Guidance and Business Highlights •Net cash used in operating... | February 17, 2022
Brandon Smith Sanjiv Patel Hideki Garren Tran Nguyen Alzheimer Association International Conference International Conference On Alzheimer

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science